Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
23.65
-0.12 (-0.50%)
At close: Mar 18, 2026, 4:00 PM EDT
23.70
+0.05 (0.21%)
After-hours: Mar 18, 2026, 7:37 PM EDT
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $2.09 billion as of March 18, 2026. Its market cap has increased by 68.63% in one year.
Market Cap
2.09B
Enterprise Value
2.02B
1-Year Change
68.63%
Ranking
Category
Stock Price
$23.65
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $2.09B, an increase of 899.97%. That is a compound annual growth rate of 25.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 2.09B | 14.23% |
| Dec 31, 2025 | 1.83B | 61.83% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
| Mar 3, 2016 | 208.60M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 2.24B |
| Veradermics | 2.20B |
| Day One Biopharmaceuticals | 2.20B |
| Galapagos NV | 2.12B |
| Nektar Therapeutics | 2.10B |
| Zai Lab | 2.08B |
| Tyra Biosciences | 2.05B |
| Adaptive Biotechnologies | 2.04B |